Home / Stocks / REGENERON PHARMACEUTICALS

REGENERON PHARMACEUTICALS

$955.4752W $600.66 – $973.36

REGN · 75886F107

2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30

Holding superinvestors

Superinvestor Shares Value Weight Change
Dodge & Cox Funds 2,324,085 $1.474B 0.8% Added
Southeastern Asset Management 114,880 $72.86M 3.9% New
Viking Global Investors 97,739 $61.99M 0.2% New

By quarter

Quarter Holders Total value
2013-06-30 1 $394K
2013-09-30 1 $548K
2013-12-31 1 $482K
2014-03-31 2 $381.6M
2014-06-30 2 $896M
2014-09-30 2 $588.6M
2014-12-31 1 $222.5M
2015-03-31 1 $255.9M
2015-06-30 1 $283.1M
2015-09-30 1 $267.7M
2015-12-31 1 $339.7M
2016-03-31 1 $254.5M
2016-06-30 1 $275.1M
2016-09-30 1 $326.2M
2016-12-31 1 $492.1M
2017-03-31 1 $572.7M
2017-06-30 1 $779.1M
2017-09-30 1 $614.2M
2017-12-31 1 $522.4M
2018-03-31 2 $1.074B
2018-06-30 2 $1.598B
2018-09-30 2 $1.884B
2018-12-31 2 $1.68B
2019-03-31 2 $1.753B
2019-06-30 2 $1.721B
2019-09-30 2 $1.604B
2019-12-31 2 $2.269B
2020-03-31 2 $1.972B
2020-06-30 2 $1.916B
2020-09-30 3 $1.458B
2020-12-31 2 $1.223B
2021-03-31 3 $511.1M
2021-06-30 3 $845.1M
2021-09-30 5 $849.8M
2021-12-31 5 $1.063B
2022-03-31 5 $2.383B
2022-06-30 4 $1.732B
2022-09-30 4 $1.761B
2022-12-31 3 $1.691B
2023-03-31 2 $1.961B
2023-06-30 2 $1.721B
2023-09-30 1 $1.953B
2023-12-31 2 $2.081B
2024-03-31 1 $2.271B
2024-06-30 1 $2.434B
2024-09-30 2 $2.483B
2024-12-31 1 $1.654B
2025-03-31 3 $1.609B
2025-06-30 2 $2.093B
2025-09-30 3 $2.705B
2025-12-31 3 $3.812B
2026-03-31 3 $3.662B
2026-06-30 3 $3.212B
2026-09-30 5 $3.824B